Dok-7/MuSK signaling and a congenital myasthenic syndrome

Acta Myologica

Volumn 27, Issue JULY, 2008, Pages 25-29

  Yamanashi, Y ^a   Higuchi, O ^b   Beeson, D ^c  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Dok 7; DOK7 congenital myasthenic syndrome; MuSK; Neuromuscular junction; Protein tyrosine kinase

Indexed keywords

AGRIN; CHOLINE ACETYLTRANSFERASE; CHOLINERGIC RECEPTOR; CHOLINESTERASE INHIBITOR; CYTOPLASM PROTEIN; DOWNSTREAM OF KINASE 7; EPHEDRINE; INSULIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MUSCLE SPECIFIC KINASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE A; RAPSYN;

AMINO TERMINAL SEQUENCE; AUTOIMMUNITY; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; CONGENITAL MYASTHENIC SYNDROME; DRUG RESPONSE; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; GENE LOCUS; GENE MUTATION; HEREDITY; HUMAN; MUSCLE CONTRACTION; MUSCLE DEVELOPMENT; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PATHOGENESIS; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SYNAPTOGENESIS;

ANIMALS; CYTOPLASM; HUMANS; MICE; MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUTATION; MYASTHENIC SYNDROMES, CONGENITAL; NEUROMUSCULAR JUNCTION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC;

EID: 51649099091     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Blume P, Hunter T. Oncogenic kinase signaling. Nature 2001;411:355-65.
2. Segawa Y, Suga H, Iwabe N, et al. Functional development of Src tyrosine kinase during evolution from a unicellular ancestor to multicellular animals. Proc Natl Acad Sci USA 2006;103:12021-6.
3. Burden SJ. The formation of neuromuscular synapses. Genes Dev 1998;12:133-48.
4. Sanes JR, Lichtman JW. Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat Rev Neurosci 2001:2:791-805.
5. Kummer TT, Misgeld T, Sanes JR. Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost. Curr Opin Neurobiol 2006;16:74-82.
6. Misgeld T. Kummer TT, Lichtman JW, et al. Agrin promotes synaptic differentiation by counteracting an inhibitory effect of neurotransmitter. Proc Natl Acad Sci USA 2005;102:11088-93.
7. Lin W, Dominguez B, Yang J, et al. Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism. Neuron 2005;46:569-79.
8. Yaffe MB. Phosphotyrosine-binding domains in signal transduction. Nat Rev Mol Biol 2002;3:177-86.
9. Zhou H, Glass DJ, Yancopoulos G, et al. Distinct domains of MuSK mediate its abilities to induce and to associate with postsynaptic specializations. J Cell Biol 1999;146:1133-46.
10. Herbst R, Burden SJ. The juxtamembrane region of MuSK has a critical role in agrin-mediated signaling. EMBO J 2000;19:67-77.
11. Herbst R, Avetisova E, Burden SJ. Restoration of synapse formation in Musk mutant mice expressing a Musk/Trk chimeric receptor. Development 2002;129:5449-60.
12. Carpino N, Wisniewski D, Strife A, et al. p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 1997;88:197-204.
13. Yamanashi Y, Baltimore D. Identification of the Abl- and ras-GAP-associated 62 kDa protein as a docking protein, Dok. Cell 1997;88:205-11.
14. Okada K, Inoue A, Okada M, et al. The muscle protein Dok-7 is essential for neuromuscular synaptogenesis. Science 2006;312:1802-5.
15. Yasuda T, Shirakata M, Iwama A, et al. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. J Exp Med 2004;200:1681-7.
16. Niki M, Di Cristofano A, Zhao M, et al. Role of Dok-1 and Dok-2 in leukemia suppression. J Exp Med 2004;200:1689-95.
17. De Chiara TM, Bowen DC, Valenzuela DM, et al. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 1996;85:513-23.
18. Armed Z, Pillay TS. Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinase-dependent signalling. Biochem J 2003;371:405-12.
19. Qian X, Ginty DD. SH2-B and APS are multimeric adapters that augment TrkA signaling. Mol Cell Biol 2001;21:1613-20.
20. Beeson D, Higuchi O, Palace J, et al. Dok-7 mutations underlie a neuromuscular junction synaptopathy. Science 2006;313:1975-8.
21. Palace J, Lashley D, Newsom-Davis J, et al. Clinical features of the DOK7 neuromuscular junction synaptopathy. Brain 2007;130:1507-15.
22. Muller JS, Herczegfalvi A, Vilchez JJ, et al. Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes. Brain 2007;130:497-506.
23. Vincent A, Lang B, Kleopa KA. Autoimmune channelopathies and related neurological disorders. Neuron 2006;52:123-38.
24. Engel AG, Ohno K, Sine SM. Sleuthing molecular targets for neurological diseases at the neuromuscular junction. Nat Rev Neurosci 2003;4:339-52.
25. th International Workshop: congenital myasthenic syndromes, 24-26 September 2004, Naarden, the Netherlands. Neuromuscul Disord 2005;15:498-512.
26. Morgan NV, Brueton LA, Cox P, et al. Mutations in the embryonal subunit of the acetylcholine receptor (CHRNG) cause lethal and Escobar variants of multiple pterygium syndrome. Am J Hum Genet 2007;79:390-5.
27. Hoffmann K, Muller JS, Stricker S, et al. Escobar syndrome is a prenatal myasthenia caused by disruption of the acetylcholine receptor fetal gamma subunit. Am J Hum Genet 2006;79:303-12.
28. Slater CR, Fawcett PR, Walls TJ, et al. Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'. Brain 2006;129:2061-76.
29. Engel AG. Light on limb-girdle myasthenia. Brain 2006;129:1938-9.
30. Weatherbee SD, Anderson KV, Niswander LA. LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction. Development 2006;133:4993-5000.
31. Hamuro J, Higuchi O, Okada K, et al. Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7. J Biol Chem 2008;283:5518-24.